Cargando…

Osteoporosis in primary biliary cholangitis

Primary biliary cholangitis (PBC) is an autoimmune cholestatic liver disease with multiple debilitating complications. Osteoporosis is a common complication of PBC resulting in frequent fractures and leading to significant morbidity in this population, yet evidence for effective therapy is lacking....

Descripción completa

Detalles Bibliográficos
Autores principales:	Danford, Christopher J, Trivedi, Hirsh D, Papamichael, Konstantinos, Tapper, Elliot B, Bonder, Alan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2018
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102495/ https://www.ncbi.nlm.nih.gov/pubmed/30131657 http://dx.doi.org/10.3748/wjg.v24.i31.3513

Ejemplares similares

Osteoporosis in Primary Biliary Cholangitis: Prevalence, Impact and Management Challenges
por: Trivedi, Hirsh D, et al.
Publicado: (2020)

Sequence of events leading to primary biliary cholangitis
por: Lenci, Ilaria, et al.
Publicado: (2023)

Management of Primary Biliary Cholangitis: Current Treatment and Future Perspectives
por: Barba Bernal, Romelia, et al.
Publicado: (2023)

Understanding fatigue in primary biliary cholangitis: From pathophysiology to treatment perspectives
por: Lynch, Erica Nicola, et al.
Publicado: (2022)

Role of endoscopy in the management of primary sclerosing cholangitis
por: Marya, Neil Bharat, et al.
Publicado: (2019)

Serological biomarkers for management of primary sclerosing cholangitis
por: Tornai, David, et al.
Publicado: (2022)

Gut microbiome in primary sclerosing cholangitis: A review
por: Little, Rebecca, et al.
Publicado: (2020)

Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies
por: Fung, Brian M, et al.
Publicado: (2019)

Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis
por: Sarcognato, Samantha, et al.
Publicado: (2021)

Acute cholangitis - an update
por: Ahmed, Monjur
Publicado: (2018)

Chromogranin A as a valid marker in oncology: Clinical application or false hopes?
por: Gkolfinopoulos, Stavros, et al.
Publicado: (2017)

Small duct primary sclerosing cholangitis: A discrete variant or a bridge to large duct disease, a practical review
por: Nguyen, Christopher M, et al.
Publicado: (2022)

Radiofrequency ablation in the management of primary hepatic and biliary tumors
por: Hendriquez, Richard, et al.
Publicado: (2022)

External validation of the United Kingdom‐primary biliary cholangitis risk scores of patients with primary biliary cholangitis treated with ursodeoxycholic acid
por: Cheung, Angela C., et al.
Publicado: (2018)

Noninvasive prognostic models, imaging, and elastography to predict clinical events in primary sclerosing cholangitis: A review
por: Russo, Mark W
Publicado: (2023)

Relationship between osteoporosis, sarcopenia, vertebral fracture, and osteosarcopenia in patients with primary biliary cholangitis
por: Saeki, Chisato, et al.
Publicado: (2020)

Baricitinib and primary biliary cholangitis
por: Gordon, Stuart C., et al.
Publicado: (2021)

Overlap Syndrome between Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
por: Sundaram, Sridhar, et al.
Publicado: (2018)

Evaluation of the United Kingdom‐primary biliary cholangitis and global primary biliary cholangitis group prognostic models for primary biliary cholangitis patients treated with ursodeoxycholic acid in the U.S. population
por: Alomari, Mohammad, et al.
Publicado: (2019)

A real‐world observational cohort of patients with primary biliary cholangitis: TARGET‐primary biliary cholangitis study design and rationale
por: Levy, Cynthia, et al.
Publicado: (2018)

Extrahepatic Manifestations of Primary Biliary Cholangitis
por: Chalifoux, Sara L, et al.
Publicado: (2017)

Obeticholic acid for primary biliary cholangitis
Publicado: (2020)

Current understanding of primary biliary cholangitis
por: Tanaka, Atsushi
Publicado: (2021)

Primary biliary cholangitis: pathogenic mechanisms
por: Prieto, Jesús, et al.
Publicado: (2021)

The Role of Epigenetics in Primary Biliary Cholangitis
por: Gerussi, Alessio, et al.
Publicado: (2022)

Obeticholic Acid for Primary Biliary Cholangitis
por: Floreani, Annarosa, et al.
Publicado: (2022)

Risk Stratification in Primary Biliary Cholangitis
por: Martini, Francesco, et al.
Publicado: (2023)

Predicting Risk in Primary Biliary Cholangitis
por: Cho, Eun Ju
Publicado: (2023)

Follicular T Helper Cell Signatures in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
por: Adam, Leonie, et al.
Publicado: (2018)

Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics
por: Park, Ji-Won, et al.
Publicado: (2022)

Metabolomic biomarkers are associated with mortality in patients with cirrhosis caused by primary biliary cholangitis or primary sclerosing cholangitis
por: Mindikoglu, Ayse L, et al.
Publicado: (2019)

Current therapies and novel approaches for biliary diseases
por: Rajapaksha, Indu G, et al.
Publicado: (2019)

Overlap syndrome of primary biliary cholangitis and primary sclerosing cholangitis: two case reports
por: Yacoub, Haythem, et al.
Publicado: (2023)

CCL24 regulates biliary inflammation and fibrosis in primary sclerosing cholangitis
por: Greenman, Raanan, et al.
Publicado: (2023)

Biomarkers for primary biliary cholangitis: current perspectives
por: Kouroumalis, Elias, et al.
Publicado: (2018)

Genetic Contribution to the Pathogenesis of Primary Biliary Cholangitis
por: Joshita, Satoru, et al.
Publicado: (2017)

New treatments/targets for primary biliary cholangitis
por: Corpechot, Christophe, et al.
Publicado: (2019)

Primary Biliary Cholangitis-associated Palmar Keratosis
por: Usami, Jun
Publicado: (2021)

Primary Biliary Cholangitis: A Case of Underdiagnosis
por: Garcês Soares, Sofia, et al.
Publicado: (2021)

Update on the Pharmacological Treatment of Primary Biliary Cholangitis
por: Floreani, Annarosa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g81f1kvn1m5lh468k5f8q2p1ce